Nitric oxide/soluble guanylyl cyclase signaling mediates depolarization-induced protection of rat mesencephalic dopaminergic neurons from MPP+ cytotoxicity

Neuroscience

Volumn 231, Issue , 2013, Pages 206-215

  Kurauchi, Y ^a   Hisatsune, A ^a   Isohama, Y ^a   Sawa, T ^b   Akaike, T ^b   Katsuki, H ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cyclic GMP; Dopamine neurons; Heme oxygenase 1; Neuronal activity; Neuroprotection; Nitric oxide

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 NITRO CYCLIC GMP; AMLODIPINE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE; KT 5823; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM ION; PROTOPORPHYRIN ZINC; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; MESENCEPHALIC DOPAMINERGIC NERVE CELL; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN METABOLISM; PROTEIN S GUANYLATION; RAT; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CYCLIC GMP; DOPAMINERGIC NEURONS; ENZYME INHIBITORS; GUANYLATE CYCLASE; MESENCEPHALON; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; THIONUCLEOTIDES;

EID: 84872296075     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.044     Document Type: Article

References (34)

1. Ahmed K.A., Sawa T., Ihara H., Kasamatsu S., Yoshitake J., Rahaman M.M., Okamoto T., Fujii S., Akaike T. Regulation by mitochondrial superoxide and NADPH oxidase of cellular formation of nitrated cyclic GMP: potential implications for ROS signalling. Biochem J 2012, 441:719-730.
2. Aumann T., Horne M. Activity-dependent regulation of the dopamine phenotype in substantia nigra neurons. J Neurochem 2012, 121:497-515.
3. Calabrese V., Scapagnini G., Ravagna A., Fariello R.G., Giuffrida Stella A.M., Abraham N.G. Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res 2002, 68:65-75.
4. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007, 8:766-775.
5. Chiueh C.C., Andoh T., Chock P.B. Roles of thioredoxin in nitric oxide-dependent preconditioning-induced tolerance against MPTP neurotoxin. Toxicol Appl Pharmacol 2005, 207:S96-S102.
6. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
7. Fahn S., Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx 2004, 1:139-154.
8. Fujii S., Sawa T., Ihara H., Tong K.I., Ida T., Okamoto T., Ahtesham A.K., Ishima Y., Motohashi H., Yamamoto M., Akaike T. The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response. J Biol Chem 2010, 285:23970-23984.
9. Gallo V., Kingsbury A., Balázs R., Jørgensen O.S. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci 1987, 7:2203-2213.
10. Huang C.L., Chen H.C., Huang N.K., Yang D.M., Kao L.S., Chen J.C., Lai H.L., Chern Y. Modulation of dopamine transporter activity by nicotinic acetylcholine receptors and membrane depolarization in rat pheochromocytoma PC12 cells. J Neurochem 1999, 72:2437-2444.
11. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13:76-86.
12. Izumi Y., Yamamoto N., Matsuo T., Wakita S., Takeuchi H., Kume T., Katsuki H., Sawada H., Akaike A. Vulnerability to glutamate toxicity of dopaminergic neurons is dependent on endogenous dopamine and MAPK activation. J Neurochem 2009, 110:745-755.
13. Johnson M.D., Ma P.M. Localization of NADPH diaphorase activity in monoaminergic neurons of the rat brain. J Comp Neurol 1993, 332:391-406.
14. Katsuki H., Takenaka C., Kume T., Kaneko S., Akaike A. Requirement of neural activity for the maintenance of dopaminergic neurons in rat midbrain slice cultures. Neurosci Lett 2001, 300:166-170.
15. Kim T.W., Lee C.H., Choi C.Y., Kwon N.S., Baek K.J., Kim Y.G., Yun H.Y. Nitric oxide mediates membrane depolarization-promoted survival of rat neuronal PC12 cells. Neurosci Lett 2003, 344:209-211.
16. Kurauchi Y., Hisatsune A., Isohama Y., Katsuki H. Nitric oxide-cyclic GMP signaling pathway limits inflammatory degeneration of midbrain dopaminergic neurons: cell type-specific regulation of heme oxygenase-1 expression. Neuroscience 2009, 158:856-866.
17. Kurauchi Y., Hisatsune A., Isohama Y., Sawa T., Akaike T., Shudo K., Katsuki H. Midbrain dopaminergic neurons utilize nitric oxide/cyclic GMP signaling to recruit ERK that links retinoic acid receptor stimulation to up-regulation of BDNF. J Neurochem 2011, 116:323-333.
18. Kurauchi Y., Hisatsune A., Isohama Y., Mishima S., Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor. Br J Pharmacol 2012, 166:1151-1168.
19. + induced substantia nigra degeneration is attenuated in nNOS knockout mice. Neurobiol Dis 1997, 4:114-121.
20. Martínez-Ruiz A., Lamas S. Two decades of new concepts in nitric oxide signaling: from the discovery of a gas messenger to the mediation of nonenzymatic posttranslational modifications. IUBMB Life 2009, 61:91-98.
21. Michel P.P., Alvarez-Fischer D., Guerreiro S., Hild A., Hartmann A., Hirsch E.C. Role of activity-dependent mechanisms in the control of dopaminergic neuron survival. J Neurochem 2007, 101:289-297.
22. Michel P.P., Agid Y. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 1996, 67:1633-1642.
23. Murer M.G., Raisman-Vozari R., Yan Q., Ruberg M., Agid Y., Michel P.P. Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons. Neuroreport 1999, 10:801-805.
24. +-induced hydroxyl radical generation via depolarization activated nitric oxide synthase in rat striatum. Brain Res 2001, 902:223-228.
25. 2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci 2005, 25:4279-4287.
26. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 1996, 93:4565-4571.
27. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006, 86:583-650.
28. Sawa T., Zaki M.H., Okamoto T., Akuta T., Tokutomi Y., Kim-Mitsuyama S., Ihara H., Kobayashi A., Yamamoto M., Fujii S., Arimoto H., Akaike T. Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate. Nat Chem Biol 2007, 3:727-735.
29. Scott J.R., Chin B.Y., Bilban M.H., Otterbein L.E. Restoring homeostasis: is heme oxygenase-1 ready for the clinic?. Trends Pharmacol Sci 2007, 28:200-205.
30. Syapin P.J. Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br J Pharmacol 2008, 155:623-640.
31. 2+. FASEB J 2011, 25:2563-2573.
32. Yamamoto N., Izumi Y., Matsuo T., Wakita S., Kume T., Takada-Takatori Y., Sawada H., Akaike A. Elevation of heme oxygenase-1 by proteasome inhibition affords dopaminergic neuroprotection. J Neurosci Res 2010, 88:1934-1942.
33. Zaki M.H., Fujii S., Okamoto T., Islam S., Khan S., Ahmed K.A., Sawa T., Akaike T. Cytoprotective function of heme oxygenase 1 induced by a nitrated cyclic nucleotide formed during murine salmonellosis. J Immunol 2009, 182:3746-3756.
34. Zecca L., Fariello R.G., Galimberti M., Racagni G., Ambrosini A. Changes in nitric oxide metabolite levels in stimulated substantia nigra neurons. Neuroreport 1997, 8:2121-2125.